Elicio Therapeutics, Inc.

NasdaqCM:ELTX Stock Report

Market Cap: US$52.6m

Elicio Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ELTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Apr 24SellUS$927,470Clal Biotechnology Industries Ltd.Company117,470US$9.44
19 Mar 24SellUS$537,524Clal Biotechnology Industries Ltd.Company82,696US$6.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ELTX?
Owner TypeNumber of SharesOwnership Percentage
Public Companies199,5641.85%
Institutions968,2098.98%
Individual Insiders2,130,03419.8%
General Public7,479,06469.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.7%.


Top Shareholders

Top 25 shareholders own 30.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.8%
Yekaterina Chudnovsky
1,915,639US$9.3m-0.24%no data
3.87%
Clal Biotechnology Industries Ltd.
416,570US$2.0m0%28.75%
2.28%
The Vanguard Group, Inc.
245,262US$1.2m8.38%no data
1.85%
CSL Limited
199,564US$973.9k0%no data
1.21%
Jay Venkatesan
130,534US$637.0k0%no data
0.66%
Geode Capital Management, LLC
71,574US$349.3k0.09%no data
0.46%
CM Management, LLC
50,000US$244.0k0%0.19%
0.46%
Arena Investors, LP
50,000US$244.0k0%0.54%
0.44%
Robert Connelly
46,970US$229.2k0%no data
0.3%
Christopher Haqq
31,981US$156.1k0%no data
0.29%
Northern Trust Global Investments
30,769US$150.2k175%no data
0.2%
State Street Global Advisors, Inc.
21,900US$106.9k0%no data
0.18%
BlackRock, Inc.
19,693US$96.1k3.73%no data
0.13%
Meyer Handelman Company LLC
13,899US$67.8k0%no data
0.12%
Citadel Advisors LLC
12,856US$62.7k0%no data
0.12%
Bridgeway Capital Management, LLC
12,500US$61.0k0%no data
0.093%
Gesiuris Asset Management SGIIC SA
9,997US$48.8k0%0.16%
0.065%
CIBC Private Wealth Advisors, Inc.
7,000US$34.2k0%no data
0.028%
Jennifer Rhodes
3,039US$14.8k0%no data
0.017%
Karen Wilson
1,871US$9.1k0%no data
0.014%
Steward Partners Investment Advisory, LLC
1,554US$7.6k0%no data
0.011%
Merrill Lynch & Co. Inc., Banking Investments
1,146US$5.6k0%no data
0.0088%
Tower Research Capital Europe Limited
950US$4.6k0%no data
0.0079%
UBS Asset Management AG
848US$4.1k4,890%no data
0.0074%
National Bank Investments Inc.
800US$3.9k-46.7%no data